LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Here, it's called by a different name. If you’re following a recipe for a cake or other dessert, sometimes you may come across heavy cream in the ingredients list. While cream is easy enough to find ...

Although some eye creams promise to completely banish dark circles, the presence of this under-eye discoloration can be due to an array of reasons, some of which a cream won’t correct ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...

I didn’t really get into hand cream until 2020, when I’d started washing my hands with impressive frequency. It wasn’t too long before I realized my body lotion wasn’t going to cut it ...

Once Dr. Craythorne's team of prescribing dermatologists has ascertained your 'Skinsize', they'll get to work creating your own custom night cream containing made-for-you actives. Not everyone's ...

Whipped cream is rarely the star of the show. It's like an extra in a movie — you barely notice it, but things don't feel right when it's missing. I decided to try eight store-bought brands of ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...